Literature DB >> 16508102

Expression, purification, crystallization and preliminary crystallographic analysis of human Pim-1 kinase.

Kevin C Qian1, Joey Studts, Lian Wang, Kevin Barringer, Anthony Kronkaitis, Charline Peng, Alistair Baptiste, Roger LaFrance, Sheenah Mische, Bennett Farmer.   

Abstract

Pim kinases, including Pim-1, Pim-2 and Pim-3, belong to a distinctive serine/threonine protein-kinase family. They are involved in cytokine-induced signal transduction and the development of lymphoid malignancies. Their kinase domains are highly homologous to one another, but share low sequence identity to other kinases. Specifically, there are two proline residues in the conserved hinge-region sequence ERPXPX separated by a residue that is non-conserved among Pim kinases. Full-length human Pim-1 kinase (1-313) was cloned and expressed in Escherichia coli as a GST-fusion protein and truncated to Pim-1 (14-313) by thrombin digestion during purification. The Pim-1 (14-313) protein was purified to high homogeneity and monodispersity. This protein preparation yielded small crystals in the initial screening and large crystals after optimization. The large crystals of apo Pim-1 enzyme diffracted to 2.1 A resolution and belong to space group P6(5), with unit-cell parameters a = b = 95.9, c = 80.0 A, beta = 120 degrees and one molecule per asymmetric unit.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 16508102      PMCID: PMC1952393          DOI: 10.1107/S1744309104029963

Source DB:  PubMed          Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun        ISSN: 1744-3091


  20 in total

Review 1.  Pim-1: a serine/threonine kinase with a role in cell survival, proliferation, differentiation and tumorigenesis.

Authors:  Z Wang; N Bhattacharya; M Weaver; K Petersen; M Meyer; L Gapter; N S Magnuson
Journal:  J Vet Sci       Date:  2001-12       Impact factor: 1.672

2.  Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.

Authors:  S Yoshida; Y Kaneita; Y Aoki; M Seto; S Mori; M Moriyama
Journal:  Oncogene       Date:  1999-12-23       Impact factor: 9.867

3.  Structure of a peptide inhibitor bound to the catalytic subunit of cyclic adenosine monophosphate-dependent protein kinase.

Authors:  D R Knighton; J H Zheng; L F Ten Eyck; N H Xuong; S S Taylor; J M Sowadski
Journal:  Science       Date:  1991-07-26       Impact factor: 47.728

4.  Synergistic roles for Pim-1 and c-Myc in STAT3-mediated cell cycle progression and antiapoptosis.

Authors:  T Shirogane; T Fukada; J M Muller; D T Shima; M Hibi; T Hirano
Journal:  Immunity       Date:  1999-12       Impact factor: 31.745

5.  The PIM-1 serine kinase prolongs survival and inhibits apoptosis-related mitochondrial dysfunction in part through a bcl-2-dependent pathway.

Authors:  M Lilly; J Sandholm; J J Cooper; P J Koskinen; A Kraft
Journal:  Oncogene       Date:  1999-07-08       Impact factor: 9.867

6.  Pim-1 kinase protects hematopoietic FDC cells from genotoxin-induced death.

Authors:  T J Pircher; S Zhao; J N Geiger; B Joneja; D M Wojchowski
Journal:  Oncogene       Date:  2000-07-27       Impact factor: 9.867

7.  Predisposition to lymphomagenesis in pim-1 transgenic mice: cooperation with c-myc and N-myc in murine leukemia virus-induced tumors.

Authors:  M van Lohuizen; S Verbeek; P Krimpenfort; J Domen; C Saris; T Radaszkiewicz; A Berns
Journal:  Cell       Date:  1989-02-24       Impact factor: 41.582

8.  Mice deficient for all PIM kinases display reduced body size and impaired responses to hematopoietic growth factors.

Authors:  Harald Mikkers; Martijn Nawijn; John Allen; Conny Brouwers; Els Verhoeven; Jos Jonkers; Anton Berns
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

9.  The human protooncogene product p33pim is expressed during fetal hematopoiesis and in diverse leukemias.

Authors:  R Amson; F Sigaux; S Przedborski; G Flandrin; D Givol; A Telerman
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

10.  The pim-1 oncogene encodes two related protein-serine/threonine kinases by alternative initiation at AUG and CUG.

Authors:  C J Saris; J Domen; A Berns
Journal:  EMBO J       Date:  1991-03       Impact factor: 11.598

View more
  2 in total

Review 1.  PIM kinase (and Akt) biology and signaling in tumors.

Authors:  Noel A Warfel; Andrew S Kraft
Journal:  Pharmacol Ther       Date:  2015-03-05       Impact factor: 12.310

2.  A novel, dual pan-PIM/FLT3 inhibitor SEL24 exhibits broad therapeutic potential in acute myeloid leukemia.

Authors:  Wojciech Czardybon; Renata Windak; Aniela Gołas; Michał Gałęzowski; Aleksandra Sabiniarz; Izabela Dolata; Magdalena Salwińska; Paweł Guzik; Magdalena Zawadzka; Ewelina Gabor-Worwa; Bożena Winnik; Małgorzata Żurawska; Ewa Kolasińska; Ewelina Wincza; Marta Bugaj; Monika Danielewicz; Eliza Majewska; Milena Mazan; Grzegorz Dubin; Monika Noyszewska-Kania; Ewa Jabłońska; Maciej Szydłowski; Tomasz Sewastianik; Bartosz Puła; Anna Szumera-Ciećkiewicz; Monika Prochorec-Sobieszek; Elżbieta Mądro; Ewa Lech-Marańda; Krzysztof Warzocha; Jerome Tamburini; Przemysław Juszczyński; Krzysztof Brzózka
Journal:  Oncotarget       Date:  2018-03-30
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.